Enliven Therapeutics, Inc.
ELVN
31 insider filings · Latest: Aug 4, 2026
Common Stock Transactions
| Txn Date | Accepted | Insider | Type | Shares | Avg Price | Value | Shares Owned | Filing |
|---|---|---|---|---|---|---|---|---|
| Aug 4, 2026 | Aug 7 12:18 AM | Mika K DerynckDirector | Sale | 158,795 | $60.21 | $9.6M | 0(D) | View → |
| Aug 4, 2026 | Aug 4 8:39 PM | Derynck Mika K | Proposed Sale | 158,795 | $58.04 | $9.2M | — | View → |
| Jul 17, 2026 | Jul 21 9:24 PM | Benjamin HohlCHIEF FINANCIAL OFFICER | Sale | 6,018 | $52.64 | $316.8K | 46,054(D) | View → |
| Jul 17, 2026 | Jul 21 9:23 PM | Helen Louise CollinsCHIEF MEDICAL OFFICER | Sale | 5,000 | $52.67 | $263.4K | 25,000(D) | View → |
| Jul 17, 2026 | Jul 17 8:36 PM | Collins Helen Louise | Proposed Sale | 15,000 | $50.86 | $762.9K | — | View → |
| Jul 6, 2026 | Jul 8 9:15 PM | Lori Anne KunkelDirector | Sale | 10,000 | $50.49 | $504.9K | 41,884(D) | View → |
| Jun 22, 2026 | Jun 24 11:19 PM | ORBIMED ADVISORS LLC10% Owner | Sale | 860,123 | $45.36 | $39.0M | 6,555,102(I) | View → |
| Jun 22, 2026 | Jun 23 12:13 AM | OrbiMed Genesis Master Fund, L.P. | Proposed Sale | 26,323 | $45.96 | $1.2M | — | View → |
| Jun 22, 2026 | Jun 23 12:10 AM | OrbiMed Private Investments VII, LP | Proposed Sale | 833,800 | $45.96 | $38.3M | — | View → |
| Jun 22, 2026 | Jun 23 12:08 AM | The Biotech Growth Trust PLC | Proposed Sale | 31,132 | $45.96 | $1.4M | — | View → |
| Jun 17, 2026 | Jun 22 9:13 PM | Benjamin HohlCHIEF FINANCIAL OFFICER | Sale | 6,018 | $43.80 | $263.6K | 51,000(D) | View → |
| Jun 17, 2026 | Jun 22 9:11 PM | Helen Louise CollinsCHIEF MEDICAL OFFICER | Sale | 5,000 | $43.80 | $219.0K | 25,000(D) | View → |
| Jun 15, 2026 | Jun 17 11:45 PM | ORBIMED ADVISORS LLC10% Owner | Sale | 281,408 | $45.02 | $12.7M | 7,388,902(I) | View → |
| Jun 17, 2026 | Jun 17 8:24 PM | Hohl Benjamin | Proposed Sale | 18,054 | $42.55 | $768.2K | — | View → |
| Jun 15, 2026 | Jun 16 1:23 AM | The Biotech Growth Trust PLC | Proposed Sale | 10,243 | $42.36 | $433.9K | — | View → |
| Jun 15, 2026 | Jun 16 1:21 AM | OrbiMed Private Investments VII, LP | Proposed Sale | 272,322 | $42.36 | $11.5M | — | View → |
| Jun 15, 2026 | Jun 16 1:18 AM | OrbiMed Genesis Master Fund, L.P. | Proposed Sale | 9,086 | $42.36 | $384.9K | — | View → |
| Jun 5, 2026 | Jun 9 8:49 PM | Lori Anne KunkelDirector | Sale | 10,000 | $34.54 | $345.4K | 51,884(D) | View → |
| Jun 5, 2026 | Jun 5 8:29 PM | Kunkel Lori Anne | Proposed Sale | 20,000 | $35.49 | $709.8K | — | View → |
| May 18, 2026 | May 20 8:18 PM | Helen Louise CollinsCHIEF MEDICAL OFFICER | Sale | 5,000 | $39.79 | $199.0K | 25,000(D) | View → |
Page 1 of 7
Next →
Stock Options & Derivatives
| Txn Date | Accepted | Insider | Type | Shares | Exercise Price | Shares Owned | Filing |
|---|---|---|---|---|---|---|---|
| Aug 4, 2026 | Aug 7 12:18 AM | Mika K DerynckDirector | Option Exercise | 158,795 | $25.28 | 0(D) | View → |
| Jul 17, 2026 | Jul 21 9:24 PM | Benjamin HohlCHIEF FINANCIAL OFFICER | Option Exercise | 1,072 | $2.48 | 84,966(D) | View → |
| Jul 17, 2026 | Jul 21 9:23 PM | Helen Louise CollinsCHIEF MEDICAL OFFICER | Option Exercise | 5,000 | $2.48 | 116,268(D) | View → |
| Jun 17, 2026 | Jun 22 9:13 PM | Benjamin HohlCHIEF FINANCIAL OFFICER | Option Exercise | 6,018 | $2.48 | 86,038(D) | View → |
| Jun 17, 2026 | Jun 22 9:11 PM | Helen Louise CollinsCHIEF MEDICAL OFFICER | Option Exercise | 5,000 | $2.48 | 121,268(D) | View → |
| May 18, 2026 | May 20 8:18 PM | Helen Louise CollinsCHIEF MEDICAL OFFICER | Option Exercise | 5,000 | $2.48 | 126,268(D) | View → |
| Apr 17, 2026 | Apr 22 12:40 AM | Helen Louise CollinsCHIEF MEDICAL OFFICER | Option Exercise | 5,000 | $2.48 | 131,268(D) | View → |
| Mar 25, 2026 | Mar 27 8:57 PM | Helen Louise CollinsCHIEF MEDICAL OFFICER | Option Exercise | 40,000 | $2.48 | 136,268(D) | View → |
| Mar 17, 2026 | Mar 19 9:50 PM | Helen Louise CollinsCHIEF MEDICAL OFFICER | Option Exercise | 5,000 | $2.48 | 176,268(D) | View → |
| Mar 10, 2026 | Mar 11 9:32 PM | Helen Louise CollinsCHIEF MEDICAL OFFICER | Option Exercise | 10,129 | $2.48 | 181,268(D) | View → |
| Mar 9, 2026 | Mar 11 9:32 PM | Helen Louise CollinsCHIEF MEDICAL OFFICER | Option Exercise | 29,871 | $2.48 | 191,397(D) | View → |
| Feb 17, 2026 | Feb 19 11:36 PM | Helen Louise CollinsCHIEF MEDICAL OFFICER | Option Exercise | 45,000 | $2.48 | 221,268(D) | View → |
| Feb 12, 2026 | Feb 18 1:01 AM | Lori Anne KunkelDirector | Grant/Award | 17,126 | $27.16 | 17,126(D) | View → |
| Feb 12, 2026 | Feb 18 1:00 AM | Richard A. HeymanDirector | Grant/Award | 19,234 | $27.16 | 19,234(D) | View → |
| Feb 12, 2026 | Feb 18 12:59 AM | Rishi GuptaDirector | Grant/Award | 35,569 | $27.16 | 1,580(D) | View → |
| Feb 12, 2026 | Feb 18 12:57 AM | Scott J. GarlandDirector | Grant/Award | 1,427 | $27.16 | 1,427(D) | View → |
| Feb 12, 2026 | Feb 18 12:56 AM | Mika K DerynckDirector | Grant/Award | 17,126 | $27.16 | 17,126(D) | View → |
| Feb 12, 2026 | Feb 18 12:56 AM | Jake BauerDirector | Grant/Award | 17,126 | $27.16 | 17,126(D) | View → |
| Feb 12, 2026 | Feb 18 12:55 AM | Rahul D. BallalDirector | Grant/Award | 17,126 | $27.16 | 17,126(D) | View → |
| Feb 12, 2026 | Feb 18 12:53 AM | Anish PatelCHIEF OPERATING OFFICER | Grant/Award | 120,000 | $27.16 | 120,000(D) | View → |
Page 1 of 2
Next →